Integrated Filling (Financials) for the Quarter and Year Ended as on 31.03.2025.
VCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxtex Cotfab Limited has submitted its integrated financial results (quarterly and annual) for the period ending 31 March 2025 to NSE as a regulatory filing. The detailed figures — including revenue, profit after tax, EBITDA margins, and auditor observations — are not available in the provided headline text. This is a standard compliance filing required under SEBI/NSE listing norms for listed companies following the close of a financial year. The actual numbers and any auditor qualifications or emphasis-of-matter notes would be contained in the attached PDF document, which has not been provided here.
Without access to the actual financial figures and auditor's report, the precise impact on shareholders cannot be assessed. Investors should review the full results document, particularly revenue trends, PAT, and any auditor remarks, to gauge the company's FY25 performance.